Family Medicine · Tampa, FL
NPI
1659660009
Since 2011
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2106 S Lois Ave
Tampa, FL, 33629
Phone (813) 844-4200
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$480K
8,441 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Shawn D Skaife prescribed most often to Medicare patients was Atorvastatin Calcium, with 352 prescriptions and refills. In total Shawn D Skaife wrote 8,441 Medicare prescriptions that cost $480K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-12-26.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 352 | 745 | 88 | $6,663 |
| Pantoprazole Sodium Generic | 349 | 535 | 82 | $6,798 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 313 | 322 | 106 | $6,906 |
| Pregabalin Generic | 270 | 277 | 46 | $4,067 |
| Montelukast Sodium Generic | 212 | 409 | 55 | $3,641 |
| Amlodipine Besylate Generic | 198 | 411 | 48 | $2,687 |
| Fluticasone Propionate Generic | 192 | 207 | 63 | $5,332 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 176 | 176 | 36 | $3,056 |
| Ondansetron Odt Ondansetron | 168 | 168 | 37 | $1,320 |
| Gabapentin Generic | 163 | 298 | 50 | $5,510 |
| Tizanidine Hcl Generic | 152 | 159 | 38 | $2,517 |
| Furosemide Generic | 146 | 269 | 39 | $1,582 |
| Losartan Potassium Generic | 140 | 275 | 35 | $2,267 |
| Levothyroxine Sodium Generic | 136 | 327 | 41 | $3,363 |
| Ibuprofen Generic | 135 | 142 | 37 | $1,582 |
Brand drugs: 1,005 claims; generic drugs: 7,341 claims; opioid claims: 389.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Shawn D Skaife were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.